The worldwide bioreactors Market is anticipated to generate revenues over USD 550 million by 2024. It will grow at
a CAGR above 18% in the forecast
period (2016-2024). The industry is driven by the demand for biologics and
adoption of single-use bioreactors (SUBs) & hybrid bioreactors. Rising
popularity of SUBs in pharmaceutical manufacturing companies is yet another key
driver.
SUBs or disposable bioreactors contain
disposable bags instead of cultural vessels. They face high demand from the
medical sector. These reactors are adopted by pharmaceutical companies to
manufacture drugs without any negotiations on their quality. These systems
differ in view of flexibility and cultural medium. Commercial bioreactors
include CellMarket Regular from Cellexus and HyClone SUB from Thermo Fisher
Scientific.
Low functional costs of SUBs and low
maintenance required for them can propel market demand from 2016 to 2024.
Moreover, convenience associated with marine-microbe culturing coupled with low
energy consumption by SUBs could favor these reactors. But low volume
capacities of SUBs can hamper the industry.
Browse Details of Report@ https://www.hexaresearch.com/research-report/bioreactors-market
The worldwide Bioreactors Market is
fragmented on the basis of products, cells, molecules, technologies, end-users,
and regions. Products include monoclonal antibodies and recombinant proteins.
Monoclonal antibodies are projected to reign owing to their efficiency in
medical treatments. Yeast, bacteria, and mammalian cells are the various cells.
Mammalian cells should be the most rapidly growing segment. This will be
attributed to their high bio-molecular effectiveness.
Recombinant proteins, monoclonal antibodies
(MAbs), gene therapy, stem cells, and vaccines are classified under molecules.
MAbs are used by biologics industry to manufacture vaccines. This may augments
the demand for bioreactors in the next eight years. Low investment costs of
SUBs to make MAbs on a small scale can add to overall market demand.
Single use bubble column bioreactor,
stirred SUBs, and wave-induced motion SUBs constitute the technologies.
Wave-induced motion SUBs are likely to notice the highest growth rate till
2024. Surging growth can be attributed to their high flexibility and short lead
times.
End-users in the Bioreactors Market
comprise R&D departments and biopharmaceutical manufacturers. The former
are sub-divided into biopharmaceutical companies, contract research
organizations (CROs), and research institutes.
Regions are Asia Pacific, North America,
Europe, and RoW (Rest of the World). North America & Europe would garner
major shares by 2024. This will be ascribed to their key biopharmaceutical
firms.
Europe is predicted to capture large shares
due to biologic drug patents reaching expiry. Also, regional assistance for
biologic manufacturers to produce drugs with high effectiveness should benefit
the region.
Asia Pacific is likely to display
significant expansion because of investment opportunities for its major
biologic manufacturers. Key firms opening their manufacturing units in Latin
America will benefit the region.
Key companies in the global Bioreactors
Market are GE Healthcare, Thermo Fisher Scientific Inc., Merck KGaA, and
Sartorius Stedim Biotech S.A. They are expected to further their product
portfolio and offer system flexibility.
This could make consumer segments
well-acquainted with various blends of bioprocessing components. It can also
help them with buying decisions. Product endorsements via commercial
manufacturing to obtain the finest application solutions may augur well for the
market.
Browse
Related Category Market Reports @
About Us:
Hexa
Research is a market research and consulting organization, offering industry
reports, custom research and consulting services to a host of key industries
across the globe. We offer comprehensive business intelligence in the form of
industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan
Shaw
Hexa
Research
Felton
Office Plaza
6265
Highway 9
Felton,
California 95018
United
States
Phone:
+1-800-489-3075
Email:
sales@hexaresearch.com
Website
- http://www.hexaresearch.com/
Visit Our
Blog: hexaresearch1.blogspot.com
No comments:
Post a Comment